Order byBest matchMost fresh
STAT2h
FDA gives Covid vaccine manufacturers instructions for next fall’s shot
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to update their vaccines.
FDA approves Novavax COVID vaccine with new conditions
President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House of Representatives try to overcome internal divisions about cuts to the Medicaid health program and tax breaks in high-cost coastal states.
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
Trump’s FDA just changed COVID vaccine rules for 2025 — will you still qualify for boosters under the new guidelines?
FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and high-risk individuals. While the FDA met to decide if vaccine formulas should change for fall 2025,
JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News
JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This comes after the Food and Drug Administration (FDA) approved the company’s COVID-19 vaccine,
Explore more
Feedback